# OnCo record angiex (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/angiex/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "angiex" ;
  schema:name "Angiex"@en ;
  schema:alternateName "Angiex, Inc."@en ;
  schema:description "Angiex is developing an antibody-drug conjugate, an antibody that carries a chemotherapy drug, aimed at a protein called TM4SF1 on cancer cells and on the blood vessels that feed tumours. Its first medicine, AGX101, is in an early trial in advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/angiex/>, <https://angiex.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://angiex.com/>, <https://angiex.com/news/31million-completion>, <https://clinicaltrials.gov/study/NCT06440005> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/sarcoma/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> .